SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-002824
Filing Date
2021-03-11
Accepted
2021-03-11 16:26:50
Documents
103
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nbrv-20201231x10k.htm   iXBRL 10-K 4177467
2 EX-4.1 nbrv-20201231xex4d1.htm EX-4.1 91108
3 EX-10.8 nbrv-20201231xex10d8.htm EX-10.8 183883
4 EX-10.18 nbrv-20201231xex10d18.htm EX-10.18 185150
5 EX-10.31 nbrv-20201231xex10d31.htm EX-10.31 179652
6 EX-10.46 nbrv-20201231xex10d46.htm EX-10.46 99618
7 EX-10.47 nbrv-20201231xex10d47.htm EX-10.47 186141
8 EX-10.48 nbrv-20201231xex10d48.htm EX-10.48 83456
9 EX-10.49 nbrv-20201231xex10d49.htm EX-10.49 94920
10 EX-21.1 nbrv-20201231xex21d1.htm EX-21.1 6326
11 EX-23.1 nbrv-20201231xex23d1.htm EX-23.1 3880
12 EX-31.1 nbrv-20201231xex31d1.htm EX-31.1 11354
13 EX-31.2 nbrv-20201231xex31d2.htm EX-31.2 10732
14 EX-32.1 nbrv-20201231xex32d1.htm EX-32.1 5782
15 EX-32.2 nbrv-20201231xex32d2.htm EX-32.2 6578
16 GRAPHIC nbrv-20201231xex10d49001.jpg GRAPHIC 5036
17 GRAPHIC nbrv-20201231x10k001.jpg GRAPHIC 30623
  Complete submission text file 0001558370-21-002824.txt   15494708

Data Files

Seq Description Document Type Size
18 EX-101.SCH nbrv-20201231.xsd EX-101.SCH 82935
19 EX-101.CAL nbrv-20201231_cal.xml EX-101.CAL 82161
20 EX-101.DEF nbrv-20201231_def.xml EX-101.DEF 440664
21 EX-101.LAB nbrv-20201231_lab.xml EX-101.LAB 744543
22 EX-101.PRE nbrv-20201231_pre.xml EX-101.PRE 712314
23 EXTRACTED XBRL INSTANCE DOCUMENT nbrv-20201231x10k_htm.xml XML 2385408
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37558 | Film No.: 21733643
SIC: 2834 Pharmaceutical Preparations